Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies

Antibodies can swiftly provide therapeutics to target disease-related molecules discovered in genomic research. Antibody engineering techniques have been actively developed and these technological innovations have intensified the development of therapeutic antibodies. From the mid-1990’s, a series of therapeutic antibodies were launched that are now being used in clinic. The disease areas that therapeutic antibodies can target have subsequently expanded, and antibodies are currently utilized as pharmaceuticals for cancer, inflammatory disease, organ transplantation, cardiovascular disease, infection, respiratory disease, ophthalmologic disease, and so on. This paper briefly describes the modes of action of therapeutic antibodies. Several non-clinical study results of the pathological changes induced by therapeutic antibodies are also presented to aid the future assessment of the toxic potential of an antibody developed as a therapeutic.     

Seroprevalence of chlamydial infection in dairy cattle in Guangzhou, southern China

Chlamydia spp. are obligate intracellular gram-negative bacteria that cause a wide range of significant diseases in humans and animals worldwide, resulting in significant economic losses. Chlamydial infection in cattle has been reported in many countries including China. However, there has been no survey of chlamydial infection of dairy cattle in Guangzhou, southern China. The objective of the present investigation was to examine the chlamydial seroprevalence in dairy cattle in Guangzhou, subtropical southern China by using an indirect hemagglutination assay (IHA). The overall seroprevalence of chlamydial infection in dairy cattle was 7.25% (29/400). Greater than or equal to eight-yr-old dairy cattle had the highest seroprevalence (10.34%), followed by those that were ≥ 6 years old or < 7 years old dairy cattle (10.20%), although there were no statistically significant differences among different groups (P > 0.05). Dairy cattle with 5 pregnancies had the highest seroprevalence (10.81%). These results indicate that chlamydial infection was present in dairy cattle in Guangzhou, subtropical southern China, and integrated strategies and measures should be executed to control and prevent chlamydial infection and disease outbreak in the study region.     

猪繁殖与呼吸综合征病毒NVDC-JXA1株膜基质蛋白单克隆抗体的研制

为制备抗猪繁殖与呼吸综合征病毒NVDC-JXA1株单克隆抗体,用纯化的猪繁殖与呼吸综合征病毒NVDC-JXA1株免疫BALB/c小鼠,最后一次免疫后第3天取其脾细胞与SP2/0细胞在聚乙二醇作用下融合,通过酶联免疫吸附试验（ELISA）和间接免疫荧光试验（IFA）筛选,以有限稀释法克隆3次,制备单克隆抗体,并对制备的单克隆抗体进行鉴定。结果表明获得了2株分泌PRRSV膜基质蛋白特异性抗体的杂交瘤细胞,命名为1D12、5H5,经鉴定其抗体亚型分别为IgG2b、IgM,2株均为κ链,腹水ELISA效价分别为1∶107和1∶105。该单克隆抗体与PRV、PPV、PCV、CSFV、JEV无交叉反应。作者成功制备了抗猪繁殖与呼吸综合征病毒NVDC-JXA1株膜基质蛋白单克隆抗体,为进一步建立相关诊断方法奠定了基础。     

The effects of non-specifically activated immunity in rabbits on primary infestation with Rhipicephalus evertsi evertsi

The secondary antibody response to sheep red blood cells and bovine serum albumin (BSA) was measured in rabbits infested with adult Rhipicephalus evertsi evertsi. The response was reduced (particularly for BSA) but still displayed anamnestic characteristics. Resistance against ixodid ticks associated with antibodies detected by gel diffusion and enzyme linked immunosorbent assay techniques early in the primary challenge was acquired by the immunized hosts only. This suggests that a non-specifically activated immune system enables hosts to develop rapid resistance against tick parasitism.     

猪伪狂犬病病毒gE抗体胶体金免疫层析检测方法的建立及应用

以纯化的抗人红细胞单链抗体(ScFv)-猪伪狂犬病病毒(PRV)gE蛋白双功能融合蛋白为诊断抗原和胶体金标记物,以羊抗猪IgG包被硝酸纤维膜作为质控带,制作检测猪伪狂犬病毒gE抗体的双抗原胶体金试纸条。利用方阵滴定试验筛选出金标抗原最佳工作浓度为17.6μg,检测线诊断抗原最佳标记量为1.76μg,血清最佳稀释度为1∶10,作用时间15 min,与猪瘟病毒(CSFV)、猪细小病毒(PPV)、猪繁殖与呼吸综合征病毒(PRRSV)、猪乙型脑炎病毒(JEV)、猪布鲁菌(Brucella)阳性血清和PRVgE缺失疫苗接种的猪免疫血清检测线均不出现红色条带,与PRV标准阳性血清反应检测线出现红色条带。试纸条操作简单,肉眼于15 min内可判定结果;试纸条在室温保存6个月,其特异性和敏感性没有明显变化;与美国IDEXX和法国LSI gE-ELISA抗体检测诊断试剂盒检测结果比较,1 164份猪血清的符合率均为90.55%。制备的胶体金试纸条具有操作简便、敏感性和特异性较高的特点,可用于PRV野毒感染的快速筛查。     

用酶联免疫吸附和正向间接血凝试验检测猪瘟抗体

应用ELISA和IHA对我省两种猪场的66份血清进行了检测,结果表明用ELISA检测两猪场免疫合格率分别为83.33%、80.5%,用IHA检测分别为90%、97.2%;两者检测结果符合率为84.8%,具有较高的群体相关性。     

Dot-ELISA检测兔疥螨抗体方法的建立和应用

将从病兔痂皮内收集的疥螨经研磨、冻融、离心后,制成可溶性抗原,作为诊断抗原,建立Dot-ELISA方法检测兔疥螨血清抗体.研究确定了该方法的最佳工作条件.制备的诊断膜片特异性强,不与兔瘟病毒、兔大肠埃希菌、兔附红细胞体等阳性血清反应.膜片具有良好的灵敏性,高免血清作1∶210稀释亦能检出;重复性试验表明该法重复性良好.诊断膜片在4 ℃保存5个月其检测活性不变.结果表明,建立的Dot-ELISA可用于免疥螨抗体的检测.     

磺胺二甲嘧啶单克隆抗体的制备及特性鉴定

采用重氮化法合成磺胺二甲嘧啶(SM_2)-人血清白蛋白(HSA)免疫抗原和SM_2~-卵清白蛋白(OVA)包被抗原。经紫外光谱扫描法确认SM_2与载体蛋白偶联成功；经计算SM_2与HSA、OVA的结合比分别为9：1和15：1。利用杂交瘤技术和有限稀释法经过5次亚克隆,得到三株特异性稳定分泌SM_2抗体的杂交瘤细胞,经鉴定该单克隆抗体免疫球蛋白亚类为IgG_1,为入链,分子量为162Ku,染色体数目90条左右,亲和常数为6．1×10~(12)M~(-1)。与其他四种磺胺药和两种载体蛋白HSA、OVA均无交叉反应。     

抗猪附红细胞体单克隆抗体的制备

以纯化的猪附红细胞体免疫BALB/c小鼠,运用淋巴细胞杂交瘤技术进行细胞融合,并用间接ELISA方法进行筛选,经过间接ELISA方法、免疫印迹和间接免疫荧光试验进行鉴定,共获得5株分泌抗猪附红细胞体单克隆抗体的杂交瘤细胞,分别命名为1H1、1H2、3A5、5B1和7E11,其单抗亚类鉴定分别属于IgG2b、IgG1、IgG2b、IgG2b和IgG2b。这5株McAb均能与猪附红细胞体全菌蛋白发生特异性反应,而不与猪肺炎支原体、猪链球菌、大肠杆菌和猪繁殖与呼吸综合征病毒发生反应,并且1H1、3A5和5B1能识别同一抗原位点,1H2和7E11识别另一抗原位点。